• Kong SY, Park JB, Kim YW, Jung SY, Yoo JS, Lee EK, Chae HJ, Kwon YM. Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance. Experimental and Molecular Medicine. 2024;56(11):2382-2394. (IF: 9.5)
• Suh PG, Chae YC, Lee YJ, Yoo JS, Kong SY. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Developmental Cell. 2023;58(4):320-334.e8. (IF: 13.417)
• Lim MC, Ha HI, Yoo JS, Shim HE, Kong SY. Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers. Journal of Gynecologic Oncology. 2020;31(6):e83-. (IF: 3.304)
• Kong SY, Yoo JS, Lee HY, Cho EH, Yoon KA, Kim MK, Joo JN, Lee ES, Kang HS, Lee SY, Lee DO, Lim MC. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. Cancer Science. 2020;111(10):3912-3925. (IF: 4.966)
• Kong SY, Lee GS, Yoo JS, Shim SH, Park IH, Lee EK, Lee ES, Kim YH, Kwon YM. Integrative in vivo drug testing using gene expression signature and patient-derived xenografts from treatment-refractory HER2 positive and triple-negative subtypes of breast cancer. Cancers. 2019;11(4):E574. (IF: 6.162)